Synthesis, characterization and cytotoxic/cytostatic activity of La(III) and Dy(III) complexes

Journal of Trace Elements in Medicine and Biology

Volumn 24, Issue 1, 2010, Pages 7-13

  Kostova, Irena ^a   Stefanova, Tsvetanka ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

Acenocoumarol; Cytotoxic cytostatic activity; Dy(III); IR; La(III); NMR spectra; Raman

Indexed keywords

ACENOCOUMAROL; DYSPROSIUM; LANTHANUM;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; FIBROSARCOMA; MELANOMA CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TOXICITY TESTING; TUMOR CELL LINE;

ACENOCOUMAROL; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOSTATIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; DYSPROSIUM; HUMANS; LANTHANUM; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; SPECTRUM ANALYSIS, RAMAN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 73449137181     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2009.06.004     Document Type: Article

References (35)

1. Cálgaro-Helena A.F., Devienne K.F., Rodrigues T., Dorta D.J., Raddi M.S.G., Vilegas W., et al. Effects of isocoumarins isolated from Paepalanthus bromelioides on mitochondria: uncoupling, and induction/inhibition of mitochondrial permeability transition. Chem Biol Interact 161 (2006) 155-164
2. Lee J.H., Bang H.B., Han S.Y., and Jun J.-G. An efficient synthesis of (+)-decursinol from umbelliferone. Tetr Lett 48 (2007) 2889-2892
3. Devienne K.F., Cálgaro-Helena A.F., Dorta D.J., Prado I.M.R., Raddi M.S.G., Vilegas W., et al. Antioxidant activity of isocoumarins isolated from Paepalanthus bromelioides on mitochondria. Phytochemistry 68 (2007) 1075-1080
4. Yu J., Wang L., Walzem R.L., Miller E.G., Pike L.M., and Patil B.S. Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J Agric Food Chem 53 (2005) 2009-2014
5. Thati B., Noble A., Creaven B.S., Walsh M., McCann M., Kavanagh K., et al. A study of the role of apoptotic cell death and cell cycle events mediating the mechanism of action of 6-hydroxycoumarin-3-carboxylatosilver in human malignant hepatic cells. Cancer Lett 250 (2007) 128-139
6. Kostova I. Synthetic and natural coumarins as cytotoxic agents. Curr Med Chem-Anti-Cancer Agents 5 (2005) 29-46
7. Kostova I. Synthetic and natural coumarins as antioxidants. Mini-Rev Med Chem 6 (2006) 365-374
8. Kostova I. Coumarins as inhibitors of HIV reverse transcriptase. Curr HIV Res 4 (2006) 347-363
9. Kostova I. Studying plant derived coumarins for their pharmacological and therapeutic properties as potential anticancer drugs. Exp Opin Drug Discov 2 (2007) 1605-1618
10. Creaven B.S., Egan D.A., Kavanagh K., McCann M., Noble A., Thati B., et al. Synthesis, characterization and antimicrobial activity of a series of substituted coumarin-3-carboxylatosilver(I) complexes. Inorg Chim Acta 359 (2006) 3976-3984
11. Budzisz E., Małecka M., Lorenz I.-P., Mayer P., Kwiecień R.A., Paneth P., et al. Synthesis, cytotoxic effect, and structure-activity relationship of Pd(II) complexes with coumarin derivatives. Inorg Chem 45 (2006) 9688-9695
12. Thati B., Noble A., Creaven B.S., Walsh M., McCann M., Kavanagh K., et al. In vitro anti-tumor and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines. Cancer Lett 248 (2007) 321-331
13. Jiao T.Q., Wua J.G., Zengb F.L., Fun Y.L., and Deng R.W. Synthesis, characterization and anticoagulant action of lanthanide complexes of Warfarin. Synth React Inorg Met-Org Chem 29 (1999) 725-735
14. Kostova I. Lanthanides as anticancer agents. Curr Med Chem-Anti-Cancer Agents 5 (2005) 591-602
15. Kostova I., Manolov I., Nicolova I., and Danchev N. New metal complexes of 4-methyl-7-hydroxycoumarin sodium salt and their pharmacological activity. Il Farmaco 56 (2001) 707-713
16. Kostova I., Manolov I., Nicolova I., Konstantinov S., and Karaivanova M. New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity. Eur J Med Chem 36 (2001) 339-347
17. Kostova I., Manolov I., Konstantinov S., and Karaivanova M. Synthesis, physicochemical characterisation and cytotoxic screening of new complexes of Ce, La and Nd with Warfarin and Coumachlor sodium salts. Eur J Med Chem 34 (1999) 63-68
18. Kostova I., Trendafilova N., and Momekov G. Theoretical and spectroscopic evidence for coordination ability of 3,3′-benzylidenedi-4-hydroxycoumarin. New neodymium(III) complex and its cytotoxic effect. J Inorg Biochem 99 (2005) 477-487
19. Kostova I., Kostova R., Momekov G., Trendafilova N., and Karaivanova M. Antineoplastic activity of new lanthanide (cerium, lanthanum and neodymium) complex compounds. J Trace Elem Med Biol 18 (2005) 219-226
20. Kostova I., Trendafilova N., and Mihaylov T. Theoretical and spectroscopic studies of pyridyl substituted bis-coumarins and their new neodymium(III) complexes. Chem Phys 314 (2005) 73-84
21. Kostova I., Momekov G., Zaharieva M., and Karaivanova M. Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins. Eur J Med Chem 40 (2005) 542-551
22. Kostova I., Manolov I., and Radulova M. Stability of the complexes of some lanthanides with coumarin derivatives. II. Neodymium(III)-4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one. Acta Pharm 54 (2004) 119-131
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
24. Stefanova T.H., Nikolova N.J., Toshkova R.A., and Neychev H.O. Antitumor and immunomodulatory effect of coumarin and 7-hydroxycoumarin against Sarcoma 180 in mice. J Exp Ther Oncol 6 (2007) 107-115
25. Hibbs Jr. J.B., Taintor R.R., Vavrin Z., and Rachlin E.M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Comm 157 (1988) 87-94
26. Albina J.E., and Reichner J.S. Role of nitric oxide in mediaton of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev 17 (1998) 39-53
27. Chang C.I., Liao J.C., and Kuo L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61 (2001) 1100-1106
28. Drapier J.C., and Hibbs Jr. J.B. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulphur prosthetic group and is reversible. J Clin Invest 78 (1986) 790-797
29. Wharton M., Granger D.L., and Durack D.T. Mitochondrial iron loss from leukemia cells injured by macrophages: a possible mechanism for electron transport chain defects. J Immunol 141 (1988) 1311-1317
30. Lepoivre M., Fieschi F., Coves J., Thelander L., and Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Bichem Biophys Res Commun 179 (1991) 442-448
31. Young M.R., Wright M.A., Matthews J.P., Malik I., and Prechel M. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. J Immunol 156 (1996) 1916-1922
32. Alleva D.G., Burger C.J., and Elgert K.D. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2. J Immunol 153 (1994) 1674-1686
33. Reisser D., Lagadec P., Arnould L., Onier N., Maupoil V., Pinnard D., et al. Nitric oxide inhibits proliferation but increases life-span of T lymphocytes in tumor-bearing rats. Cancer Immunol Immunother 46 (1998) 160-166
34. Lejeune P., Lagadec P., Onier N., Pinard D., Ohshima H., and Jeannin J.F. Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152 (1994) 5077-5083
35. Hegardt P., Widegren B., and Sjögren H.-O. Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas. Cell Immunol 200 (2000) 116-127